Curry International Tuberculosis Center (CITC)

Location(s): Ethiopia; Kenya; Tanzania; Zimbabwe; Botswana; Namibia; China; India; Nepal; Indonesia; Thailand; Mexico; Caribbean

Description

The Curry International Tuberculosis Center (CITC) creates, enhances, and disseminates state-of-the-art resources and models of excellence and performs research to control and eliminate tuberculosis in the United States and internationally.

Archived Projects: 71

Project Investigator Topics Location Start End
Delete link
Core Prevention and Control Project Philip Hopewell, MD Tuberculosis United States
Targeted Testing and Treatment of Latent TB Infection Philip Hopewell, MD Tuberculosis United States
Model Tuberculosis Education and Training Center Philip Hopewell, MD Tuberculosis, Training and Capacity Building
Evaluation of Smear Microscopy Methods Philip Hopewell, MD Tuberculosis
Tuberculosis Epidemiologic Studies Consortium Project George W. Rutherford, MD Tuberculosis United States
Regional TB Training and Medical Consultation Center (RTMCC) Philip Hopewell, MD Tuberculosis, Training and Capacity Building
Impact of the Number of Contacts on the Transmission of Tuberculosis - a Molecular Epidemiologic Study Payam Nahid, MD, MPH Tuberculosis
Systematic Review Series on "Antibody and Antigen Detection for the Immunodiagnosis of Tuberculosis" Philip Hopewell, MD Tuberculosis
TBRU: Tuberculosis Research Unit, Case Western Reserve University Philip Hopewell, MD Tuberculosis
Regional TB Training and Medical Consultation Center (RTMCC) Philip Hopewell, MD Tuberculosis, Training and Capacity Building
Tuberculosis Training Scholarships (TBTS) Philip Hopewell, MD Tuberculosis, Training and Capacity Building
TB Physician Services Payam Nahid, MD, MPH Tuberculosis, Epidemiology and Surveillance, Implementation and Behavioral Science United States
Population-Based Molecular Epidemiology of Tuberculosis Philip Hopewell, MD Tuberculosis United States
Systematic Review Series: Non-commercial antibody detection for the dx of pulmonary TB Payam Nahid, MD, MPH Tuberculosis
Coordination of the Development of Tuberculosis Contact Investigation Policy Philip Hopewell, MD Tuberculosis
Regional Capacity Building in Low Incidence Areas Philip Hopewell, MD Tuberculosis
Tuberculosis Epidemiologic Studies Consortium George W. Rutherford, MD Tuberculosis United States
Task Order #22 Assessing the Integration of Social Network Analysis into Tuberculosis Contact Investigation Practice Philip Hopewell, MD Tuberculosis
UCSF-FIND Uganda Project Laurence Huang, MD Tuberculosis, Drug and Diagnostics Development Uganda
Systematic Reviews of the Scientific Bases of Antituberculosis Chemotherapy ("Dogma" Review) Philip Hopewell, MD Tuberculosis
Frontloaded Sputum Microscopy J. Luke Davis, MD Tuberculosis United States
Sputum Processing Methods J. Luke Davis, MD Tuberculosis, Drug and Diagnostics Development Uganda
Tuberculosis Risk Reduction Project George W. Rutherford, MD Tuberculosis, Systematic Reviews and Guideline Development, Epidemiology and Surveillance United States
Interferon-Gamma Release Assays for the Diagnosis of Tuberculosis in Adults Adithya Cattamanchi, MD Tuberculosis, Drug and Diagnostics Development Uganda; Tanzania; Zambia; South Africa; China; India; Iran; Turkey; Bulgaria
Conducting Infection Control Assessment and Developing Educational Materials for Mexico Philip Hopewell, MD Tuberculosis Mexico
Tuberculosis Trials Consortium (TBTC) Payam Nahid, MD, MPH Tuberculosis
Oral Wash for Nucleic Acid Diagnosis and Prognosis of TB in HIV-Infected Ugandans J. Luke Davis, MD HIV/AIDS Uganda
Capacity Building for Management of First Line Drug Resistant TB in Tanzania Elizabeth Fair, PhD, MPH Tuberculosis, Training and Capacity Building Tanzania
TB Physician Services Contract Payam Nahid, MD, MPH Tuberculosis, Epidemiology and Surveillance, Implementation and Behavioral Science United States
FIND Xpert MTB assay collaboration at Mulago Hospital Laurence Huang, MD Tuberculosis Uganda
Fitness Cost and Compensation in Quinolone-Resistant Mycobacterium tuberculosis Midori Kato-Maeda, MD Tuberculosis United States
Evaluation of interferon Gamma Release Assays in Overseas Immigration Examination of Children in Moderate and high Burden Countries Elizabeth Fair, PhD, MPH Tuberculosis, Pediatrics United States
Effectiveness of QuantiFERON-TB Gold (QFT-G) in Contact Tracing Elizabeth Fair, PhD, MPH Tuberculosis, Drug and Diagnostics Development Tanzania
Master Agreement: Tuberculosis Epidemiologic Studies Consortium Philip Hopewell, MD Tuberculosis
Core Requirements: Tuberculosis Epidemiologic Studies Consortium Elizabeth Fair, PhD, MPH Tuberculosis United States
Tuberculosis Epidemiologic Studies Consortium George W. Rutherford, MD Tuberculosis, Epidemiology and Surveillance United States
Cepheid 077B-C: Evaluation of the Xpert® MTB/RIF Assay Anne F. Luetkemeyer, MD Tuberculosis Uganda; United States
HQHIV1003203 Philip Hopewell, MD HIV/AIDS, Tuberculosis
Population-Based Molecular Epidemiology of Tuberculosis in San Francisco Philip Hopewell, MD Tuberculosis
Regional Training and Medical Consultation Center Philip Hopewell, MD Training and Capacity Building United States
Quantiferon+Pamp Payam Nahid, MD, MPH Tuberculosis
Oral Wash for Nucleic Acid Diagnosis and Prognosis of TB in HIV-infected Ugandans J. Luke Davis, MD HIV/AIDS, Tuberculosis, Drug and Diagnostics Development Uganda
Clinical and Public Health Impact of Automated Nucleic Acid Testing (Cepheid GeneXpert) to Rule-out Tuberculosis in San Francisco J. Luke Davis, MD Tuberculosis United States
Accelerating and Intensifying Tuberculosis Case Finding in Uganda Courtney V. Broaddus, MD Tuberculosis Uganda
TB Physician Services Contract Payam Nahid, MD, MPH Tuberculosis United States
Interplay of Strain and Ethnicity in the Immune Response to M. tuberculosis Payam Nahid, MD, MPH Tuberculosis United States
Novel Maltodextrin-Based, Bacterial Targeting Probes for Bioimaging of Viable MTB in Vivo Payam Nahid, MD, MPH Drug and Diagnostics Development United States
Novel Technologies to Increase the Accessibility and Accuracy of Tuberculosis Diagnostic Services in Hanoi Province, Vietnam Adithya Cattamanchi, MD Tuberculosis, Drug and Diagnostics Development Viet Nam
A User-Friendly Epidemic-Economic Model of Diagnostic Tests for Tuberculosis Adithya Cattamanchi, MD Tuberculosis, Drug and Diagnostics Development, Epidemiology and Surveillance United States
T-cell Epitope Contract Payam Nahid, MD, MPH United States
TB TO 2015 Philip Hopewell, MD Tuberculosis Ethiopia; Kenya; Tanzania; Botswana; China; India; Nepal; Indonesia; Thailand; Mexico
TB Guidline Observation and Adherence in Low Income Countries (TB GOAL) Adithya Cattamanchi, MD Tuberculosis, Systematic Reviews and Guideline Development Uganda
Master Agreement: Tuberculosis Indefinite Quantity Contract (TB IQC) Philip Hopewell, MD Tuberculosis
M tuberculosis Cells from Patients with Tuberculosis Midori Kato-Maeda, MD Tuberculosis Tanzania; Zimbabwe; Panama
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects Anne F. Luetkemeyer, MD HIV/AIDS, Tuberculosis United States
Immunodiagnosis of Active Tuberculosis in HIV-Infected Patients Adithya Cattamanchi, MD HIV/AIDS, Tuberculosis, Drug and Diagnostics Development Uganda
Comparative Effectiveness of Rapid Diagnostics for Tuberculosis in Uganda Adithya Cattamanchi, MD Tuberculosis, Drug and Diagnostics Development, Epidemiology and Surveillance Uganda
Real-Time Reagent-Free Noninvasive Diagnosis of Tuberculosis Payam Nahid, MD, MPH Tuberculosis United States
Mobile Phone Platform for Genomic Disease Detection Adithya Cattamanchi, MD Tuberculosis, Drug and Diagnostics Development, Genetics Viet Nam
TB Physician Services Contract Payam Nahid, MD, MPH Tuberculosis United States
Tuberculosis Epidemiology and Novel Transmission Routes in Rural Tanzania Philip Hopewell, MD Tuberculosis, Epidemiology and Surveillance Tanzania
A Novel Proteomic Approach to Tuberculosis Biomarker Discovery using Human Exosomes J. Luke Davis, MD Tuberculosis United States
UCB-UCSF-MU Research Training on Tuberculosis (TB) and Other Pulmonary Complications of HIV J. Luke Davis, MD HIV/AIDS, Opportunistic Infection, Tuberculosis, Chronic Respiratory Disease, Health Systems Strengthening, Training and Capacity Building, Training International Scholars and Clinicians Uganda
Effect of Drug Resistance on Transmissibility and Pathogenicity of M. Tuberculosis Philip Hopewell, MD Tuberculosis United States
Utility of Contact Investigation of Drug Susceptible and Resistant Tuberculosis in Tanzania Elizabeth Fair, PhD, MPH Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Epidemiology and Surveillance Tanzania
Exosomes as Biomarkers for Tuberculosis J. Luke Davis, MD Tuberculosis United States
ATS Implementation Guide and Training Modules Philip Hopewell, MD Tuberculosis, Training and Capacity Building Kenya; Tanzania; China; India; Nepal; Indonesia; Mexico
Improving Early Identification of Drug Resistant Tuberculosis in HIV Prevalent Settings John J. Metcalfe, MD HIV/AIDS, Tuberculosis Zimbabwe
Investigation of Indoor Solid Fuel and Kerosene Use as Tuberculosis Risk Factors Philip Hopewell, MD Tuberculosis Nepal
Molecular Epidemiology and Geospatial Analysis of Tuberculosis Transmission in Uganda Gabriel Chamie, MD HIV/AIDS, Tuberculosis, Epidemiology and Surveillance Uganda
Tuberculosis Epidemiologic Studies Consortium George W. Rutherford, MD Tuberculosis United States